Discover the transformation of antibody-drug conjugates (ADCs) from experimental to essential in cancer therapy with new ...
Over the last several decades, mounting interest has positioned bioconjugate therapeutics as one of the most promising biopharmaceutical modalities. Work in chemical biology, including novel ...
Antibody-drug conjugates (ADCs) represent the most successful class of active targeting drug-delivery systems, however, despite the increasing number of FDA approvals treatment-related adverse events ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results